Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis

Similar Items

• Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
  by: Martínez-Pérez Rosalía, et al.
  Published: (2012-11-01)
• Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
  by: Chen HH, et al.
  Published: (2016-02-01)
• Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
  by: Martínez-Pérez Rosalia, et al.
  Published: (2011-11-01)
• Optimal dose of etanercept in the treatment of rheumatoid arthritis
  by: Curtis EM, et al.
  Published: (2014-03-01)
• The effectiveness of etanercept and adalimumab on anemia of chronic disease and serum hepcidin in patients with rheumatoid arthritis, a comparative study
  by: M.H. Abu-Zaid, et al.
  Published: (2018-10-01)